Featured products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC7129	GANT61(NSC 136476) Featured	GANT 61(NSC 136476) is a small molecule inhibitor of Gli1 and Gli2.
DC20388	GAPDS Featured	GAPDS is a small molecule that targets the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
DC26031	Gardiquimod trifluoroacetate Featured	Gardiquimod trifluoroacetate is a specific TLR7 agonist which can also inhibit HIV-1 reverse transcriptase.
DC12671	Gboxin Featured	Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma.
DC7130	GBR 12935 dihydrochloride Featured	GBR 12935 is a potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).
DC10474	GBT-440(Voxelotor) Featured	GBT-440(Voxelotor) is a novel small molecule hemoglobin modifier which increases hemoglobin oxygen affinity.
DC10896	GCN2-IN-1 Featured	GCN2-IN-1 is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with IC50s of <0.3 μM in the enzyme and cell assay.
DC7416	Taselisib（GDC-0032） Featured	GDC-0032 is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with IC50 of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.
DC3109	Ipatasertib (GDC-0068) Featured	GDC-0068 is a highly selective pan-Akt inhibitor targeting Akt1, Akt2 and Akt3 with IC50 of 5 nM, 18 nM and 8 nM, respectively.
DC10153	GDC-0077 Featured	GDC-0077 is an orally available PI3K inhibitor with potential antineoplastic activity. GDC-0077 is extracted from patent WO 2017001645 A1, formula I.
DC9708	Paxalisib (GDC-0084) Featured	GDC-0084 （RG7666）, is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
DC8597	Gdc-0152 Featured	GDC-0152 is a potent inhibitor of IAPs; binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with K(i) values of 28, 14, 17, and 43 nM, respectively.
DC8519	GDC046 Featured	GDC046 is a potent lead analog with good kinase selectivity, physicochemical properties, and pharmacokinetic profile.
DC10485	GDC0575（ARRY-575，RG7441） Featured	GDC0575（ARRY-575，RG7441）is a small molecule inhibitor of cell cycle checkpoint kinase 1 (Chk1), with potential chemosensitization activity.
DC8000	GDC-0623 Featured	GDC-0623 is a potent, ATP-uncompetitive inhibitors of MEK1(Ki=0.13 nM, +ATP).
DC9942	GDC-0853(RG7845) Featured	GDC-0853 is orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity.
DC1054	GDC0941(Pictilisib) Featured	GDC-0941 is a potent inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 3 nM, 33 nM, 3 nM and 75 nM, respectively.
DC4177	Cobimetinib(GDC-0973; XL518) Featured	GDC-0973 is a potent, highly selective inhibitor of mitogen-activated protein kinase kinase, also known as MEK, a serine/threonine kinase that is a component of the RAS/RAF/MEK/ERK pathway.
DC5081	Apitolisib Featured	GDC-0980 (RG7422) is a potent, class I PI3K inhibitor for PI3Kα/β/δ/γ with IC50 of 5 nM/27 nM/7 nM/14 nM, respectively. Also a mTOR inhibitor with Ki of 17 nM, and highly selective versus others PIKK family kinases.
DC7766	Ravoxertinib Featured	GDC-0994 is a potent, orally available ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.
DC22324	GDP366 Featured	GDP366, a dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells.
DC10667	Gea3162 Featured	Gea 3162 is a potent inhibitor of ADP-induced platelet aggregation in platelet rich plasma (PRP). GEA 3162 stimulates cGMP production in platelets, granulocytes, and polymorphonuclear leukocytes.
DC11504	GeA-69 Featured	GeA-69(GeA69) is a potent, selective, allosteric, cell-active PARP14 macrodomain 2 (MD2) inhibitor with Kd of 0.86 uM in ITC assays.
DC10721	Gefapixant(AF-219,MK-7264) Featured	Gefapixant(AF-219,MK-7264) is novel P2X3 receptor antagonist.
DC2103	Gefitinib (ZD1839) Featured	Gefitinib (Iressa, ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.
DC12392	Gemcabene Featured	Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.
DC8487	Gemcitabine elaidate Featured	Gemcitabine elaidate is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity.
DC2107	Gemcitabine HCl (Gemzar,LY188011) Featured	Gemcitabine Hydrochloride (Gemzar) is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively,showed potent activity against COVID-19(SARS-COV-2) with EC50 MERS-COV(1.216), SARS-COV(4.9
DC10590	Gemcitabine monophosphate Featured	Gemcitabine monophosphate disodium salt, also called GemMP, is a monophosphate derivative of Gemcitabine.
DC3159	Gemifioxacin Featured	Gemifloxacin mesylate (trade name Factive, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia.

Featured products

Customized Consultation X

Your information is safe with us. * Required Fields.